Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:PETX
Date6/2013
Raised$51M
Post IPO Valuation$223M

General Information

Websitearatanatherapeuti...
CategoryBioTech
Phone913-951-2130
Employees

Offices

Kansas City, USA
1901 Olathe Blvd
Kansas City, KS, 66103
USA

People

Founder, President & CEO
Chairman, Board of Directors
CFO
CCO
CSO
Chief Financial Officer
Vice President of Corporate Development
Vice President of Drug Development
Show All People

Acquisitions

Total$63.3M
Okapi Sciences, 1/2014 €33.3M
Vet Therapeutics, 10/2013 $30M

Funding

TOTAL $76.8M
FUNDING TOTAL $76.8M
Series A, 1/2011
MPM Capital
Avalon Ventures
Kansas Bioscience Authority
$20M
Series B, 12/2011
MPM Capital
Avalon Ventures
Cultivian Ventures
$15M
Series C, 1/2013
$12M
Venture Round, 10/2013
$29.8M

Tags

Aratana Therapeutics

Aratana Therapeutics, a Kansas City, Kansas-based newly-formed company focused on the development of innovative therapies for the animal health industry.

Recent Milestones

Videos

Screenshots

Stock Price

Sources

  1. Aratana Therapeutics (PETX) Nabs Okapi Sciences For E33.3 Million (biospace.com) [edit]
  2. Aratana Therapeutics Snags Vet Therapeutics for $30 Million+ Cash-Stock Deal (biospace.com) [edit]
  3. Aratana Therapeutics Closes $20 Series A Financing (finsmes.com) [edit]
  4. Aratana Therapeutics Closes $15M Series B Financing (finsmes.com) [edit]
  5. Aratana Closes $12 Million Series C Financing to Fund Pipeline Expansion (reuters.com) [edit]
  6. SEC (sec.gov) [edit]
Edit This Page
Last Edited 1/6/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy